Your browser doesn't support javascript.
loading
Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.
Higashi, Nobuaki; Maeda, Rino; Sesoko, Nakaba; Isono, Momoko; Ishikawa, Sodai; Tani, Yurina; Takahashi, Katsuhiko; Oku, Teruaki; Higashi, Kyohei; Onishi, Shoichi; Nakajima, Motowo; Irimura, Tatsuro.
Affiliation
  • Higashi N; Department of Biochemistry, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan. Electronic address: n-higashi@hoshi.ac.jp.
  • Maeda R; Department of Biochemistry, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
  • Sesoko N; Department of Biochemistry, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
  • Isono M; Department of Biochemistry, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
  • Ishikawa S; Department of Biochemistry, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
  • Tani Y; Department of Biochemistry, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
  • Takahashi K; Department of Biochemistry, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
  • Oku T; Department of Microbiology, Hoshi University School of Pharmacy, 2-4-41, Ebara, Shinagawa-ku, Tokyo, 142-8501, Japan.
  • Higashi K; Department of Clinical and Analytical Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
  • Onishi S; Department of Clinical and Analytical Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
  • Nakajima M; SBI Pharmaceuticals Co., Ltd., 1-6-1, Roppongi, Minato-ku, Tokyo, 106-6020, Japan.
  • Irimura T; Division of Glycobiologics, Intractable Disease Research Center, Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Biochem Biophys Res Commun ; 520(1): 152-158, 2019 11 26.
Article in En | MEDLINE | ID: mdl-31582210
ABSTRACT
We examined whether chondroitin sulfates (CSs) exert inhibitory effects on heparanase (Hpse), the sole endoglycosidase that cleaves heparan sulfate (HS) and heparin, which also stimulates chemokine production. Hpse-mediated degradation of HS was suppressed in the presence of glycosaminoglycans derived from a squid cartilage and mouse bone marrow-derived mast cells, including the E unit of CS. Pretreatment of the chondroitin sulfate E (CS-E) with chondroitinase ABC abolished the inhibitory effect. Recombinant proteins that mimic pro-form and mature-form Hpse bound to the immobilized CS-E. Cellular responses as a result of Hpse-mediated binding, namely, uptake of Hpse by mast cells and Hpse-induced release of chemokine CCL2 from colon carcinoma cells, were also blocked by the CS-E. CS-E may regulate endogenous Hpse-mediated cellular functions by inhibiting enzymatic activity and binding to the cell surface.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Cells / Chondroitin Sulfates / Glucuronidase Limits: Animals / Humans Language: En Journal: Biochem Biophys Res Commun Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Cells / Chondroitin Sulfates / Glucuronidase Limits: Animals / Humans Language: En Journal: Biochem Biophys Res Commun Year: 2019 Document type: Article